ClinicalTrials.govpublic full text
Study BT5528-100 in Patients With Advanced Solid Tumors Associated With EphA2 Expression
advanced solid tumor historically known for high epha2 expression, urothelial cancer, ovarian cancer, non-small cell lung cancer, head and neck cancer, triple negative breast cancer, gastric/upper gastrointestinal cancer, epha2, bladder cancer, nsclc, tnbc, gastric cancer
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 837556
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.